Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Analgesic compounds reported by Gruenenthal in patent literature

March 12, 2002

New drug candidate for Alzheimer's disease emerges from Samaritan-Georgetown alliance

March 12, 2002

Botulinum toxin type A safe and potentially effective adjunct for poststroke upper limb spasticity

March 12, 2002

Treatment-resistant schizophrenics benefit from addition of Ginkgo biloba extract to therapy

March 12, 2002

Rebif approved, launched in U.S. for relapsing forms of multiple sclerosis

March 12, 2002

Capsaicin receptor ligands for the treatment of pain in the Neurogen pipeline

March 11, 2002

Novel series of compounds for neurodegenerative disorders disclosed in patent literature

March 11, 2002

Method for regeneration of nerve tissue described at the University of Texas

March 11, 2002

Pozen submits final mouse carcinogenicity results for MT-100

March 11, 2002

CPMP recommends approval of Avonex in early-stage MS

March 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...